The Surgical Integrated System Ultrasonic Head segmentation by application distinguishes five principal clinical domains: General Surgery, Cardiothoracic Surgery, Neurosurgery, Orthopedic Surgery, and ENT Surgery. Each domain reflects a discrete set of procedural requirements that drive distinct hardware configurations and software algorithms, thereby shaping revenue distribution across the market. General Surgery, representing roughly 30 % of total sales, dominates due to its high procedure volume and broad adoption of ultrasonic dissection for tissue transection. Cardiothoracic Surgery follows at 25 %, where ultrasonic heads enable precise vessel sealing under constrained operative fields. Neurosurgery accounts for 20 % of the market, leveraging the technology’s ability to minimize collateral thermal injury during delicate cranial interventions. Orthopedic applications, contributing 15 %, focus on bone cutting and cement removal, while ENT procedures comprise the remaining 10 %, primarily for delicate soft‑tissue excision in confined anatomical spaces. This application‑driven taxonomy quantifies how procedural diversity translates into proportional market share, providing a clear framework for forecasting growth within each clinical segment.